{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:47:36Z","timestamp":1792273656058,"version":"4.4.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007123","name":"The Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neubiorev.2025.106313","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:13:12Z","timestamp":1754428392000},"page":"106313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inflammation manipulation and a complement-centered reboot of the Toxoplasma gondii model of schizophrenia"],"prefix":"10.1016","volume":"177","author":[{"given":"Jianchun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Severance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13099-024-00602-2","article-title":"A systematic review and meta-analysis of protozoan parasite infections among patients with mental health disorders: an overlooked phenomenon","volume":"16","author":"Abdoli","year":"2024","journal-title":"Gut Pathog."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41537-025-00630-0","article-title":"Toxoplasma gondii associated with psychotic symptom load and cortisol in severe mental illness","volume":"11","author":"Andreou","year":"2025","journal-title":"Schizophr. (Heide )"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12026-013-8384-0","article-title":"C-reactive protein and the biology of disease","volume":"56","author":"Ansar","year":"2013","journal-title":"Immunol. Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12879-024-09724-z","article-title":"\"Sero-prevalence of toxoplasma gondii before and during the COVID-19 pandemic in northwestern Iran","volume":"24","author":"Asfaram","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10875-008-9255-7","article-title":"Serological responses to microbial antigens in celiac disease patients during a gluten-free diet","volume":"29","author":"Ashorn","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbi.2024.03.041","article-title":"CSMD1 regulates brain complement activity and circuit development.\"","volume":"119","author":"Baum","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106313_bib7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.neubiorev.2025.106313_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-800964-2.00010-0","article-title":"Animal models: no model is perfect, but many are useful","author":"Baxter","year":"2016","journal-title":"Viral Pathog."},{"key":"10.1016\/j.neubiorev.2025.106313_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2012.06.019","article-title":"Updating the mild encephalitis hypothesis of schizophrenia","volume":"42","author":"Bechter","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106313_bib10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2013.09.023","article-title":"The epidemiologic evidence linking autoimmune diseases and psychosis","volume":"75","author":"Benros","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","article-title":"A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis","volume":"171","author":"Benros","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib13","unstructured":"BioPharmaPEG. (2022). Complement inhibitors as therapeutic agents. Retrieved June 29, 2025, from \u3008https:\/\/www.biochempeg.com\/article\/281.html\u3009."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2025.106313_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0463.2009.02453.x","article-title":"Communication between toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence","volume":"117","author":"Blader","year":"2009","journal-title":"Apmis"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib15","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1172\/JCI78366","article-title":"The microbiome revolution","volume":"124","author":"Blaser","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"6285","key":"10.1016\/j.neubiorev.2025.106313_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106313_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-immunol-101921-035639","article-title":"Complement in the brain: contributions to neuroprotection, neuronal plasticity, and neuroinflammation","volume":"41","author":"Bohlson","year":"2023","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3389\/fimmu.2017.01080","article-title":"Host-Toxoplasma gondii coadaptation leads to fine tuning of the immune response.\"","volume":"8","author":"Brasil","year":"2017","journal-title":"Front Immunol."},{"issue":"38","key":"10.1016\/j.neubiorev.2025.106313_bib19","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1073\/pnas.1102999108","article-title":"\"Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve","volume":"108","author":"Bravo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2025.106313_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbi.2019.01.026","article-title":"\"Large-scale study of toxoplasma and cytomegalovirus shows an association between infection and serious psychiatric disorders.\"","volume":"79","author":"Burgdorf","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ACI.0000000000001034","article-title":"\"Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management","volume":"24","author":"Buso","year":"2024","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbi.2025.03.026","article-title":"\"The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans","volume":"127","author":"Byrne","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2025.106313_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbi.2020.06.017","article-title":"\"Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls","volume":"89","author":"Cai","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2025.106313_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.868727","article-title":"\"Unifying virulence evaluation in toxoplasma gondii: a timely task.\"","volume":"12","author":"Calero-Bernal","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.neubiorev.2025.106313_bib25","doi-asserted-by":"crossref","first-page":"1464108","DOI":"10.3389\/fimmu.2024.1464108","article-title":"\"The emerging role of toxoplasma gondii in periodontal diseases and underlying mechanisms","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2023.100080","article-title":"\"COVID-19 and mental health risks in children: a role for biomarkers of inflammation, stress and the gut-brain axis","volume":"9","author":"Carmichael","year":"2023","journal-title":"Biomark. Neuropsychiatry"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib27","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/glia.23816","article-title":"\"Toxoplasma infection induces microglia-neuron contact and the loss of perisomatic inhibitory synapses","volume":"68","author":"Carrillo","year":"2020","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib28","first-page":"3365","article-title":"\"Complement-dependent loss of inhibitory synapses on pyramidal neurons following toxoplasma gondii infection","volume":"168","author":"Carrillo","year":"2024","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/schbul\/sbm008","article-title":"\"Effects of toxoplasma gondii infection on the brain","volume":"33","author":"Carruthers","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/ADR-170017","article-title":"\"Genetic, transcriptome, proteomic, and epidemiological evidence for Blood-Brain barrier disruption and polymicrobial brain invasion as determinant factors in alzheimer's disease","volume":"1","author":"Carter","year":"2017","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106313_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/fpd.2010.0795","article-title":"\"Toxoplasma in animals, food, and humans: an old parasite of new concern","volume":"8","author":"Cenci-Goga","year":"2011","journal-title":"Foodborne Pathog. Dis."},{"key":"10.1016\/j.neubiorev.2025.106313_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.schres.2024.07.039","article-title":"\"Analysis of the complement component C4 gene with schizophrenia subphenotypes","volume":"271","author":"Chen","year":"2024","journal-title":"Schizophr. Res"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","article-title":"\"Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study","volume":"200","author":"Chen","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106313_bib34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s00436-017-5478-y","article-title":"\"Toxoplasma gondii and schizophrenia: a review of published RCTs","volume":"116","author":"Chorlton","year":"2017","journal-title":"Parasitol. Res"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib35","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4049\/jimmunol.172.3.1670","article-title":"\"The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1\/CD35)","volume":"172","author":"Clemenza","year":"2004","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13110937","article-title":"\"Increase in congenital toxoplasmosis during the COVID-19 pandemic in the US","volume":"13","author":"Contopoulos-Ioannidis","year":"2024","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib37","first-page":"517","article-title":"\"Acute phase response in animals: a review","volume":"59","author":"Cray","year":"2009","journal-title":"Comp. Med"},{"key":"10.1016\/j.neubiorev.2025.106313_bib38","first-page":"1467538","article-title":"\"The regulation of inflammation by innate and adaptive lymphocytes","author":"Cronkite","year":"2018","journal-title":"J. Immunol. Res 2018"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"\"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"\"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"\"Associations between Non-neurological autoimmune disorders and psychosis: a Meta-analysis","volume":"85","author":"Cullen","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"7484","key":"10.1016\/j.neubiorev.2025.106313_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"\"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106313_bib43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1461145710001410","article-title":"\"Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies","volume":"14","author":"Dean","year":"2010","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/schbul\/sbr100","article-title":"\"How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder","volume":"38","author":"Demjaha","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"16","key":"10.1016\/j.neubiorev.2025.106313_bib45","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3748\/wjg.v13.i16.2312","volume":"13","author":"Desplat-Jego","year":"2007","journal-title":"World J. Gastroenterol. WJG"},{"issue":"2-3","key":"10.1016\/j.neubiorev.2025.106313_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.schres.2011.04.010","article-title":"\"Artemisinin reduces the level of antibodies to gliadin in schizophrenia","volume":"129","author":"Dickerson","year":"2011","journal-title":"Schizophr. Res"},{"issue":"1-3","key":"10.1016\/j.neubiorev.2025.106313_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.schres.2009.05.005","article-title":"\"A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for toxoplasma gondii","volume":"112","author":"Dickerson","year":"2009","journal-title":"Schizophr. Res"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/schbul\/14.4.489","article-title":"\"Genetic hypothesis of idiopathic schizophrenia: its exorphin connection","volume":"14","author":"Dohan","year":"1988","journal-title":"Schizophr. Bull."},{"issue":"22","key":"10.1016\/j.neubiorev.2025.106313_bib49","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJM198005293022214","article-title":"\"Celiac disease and schizophrenia","volume":"302","author":"Dohan","year":"1980","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pnpbp.2006.10.012","article-title":"\"Paralytic ileus associated with combined atypical antipsychotic therapy","volume":"31","author":"Dome","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","article-title":"\"The history of toxoplasma gondii--the first 100 years","volume":"55","author":"Dubey","year":"2008","journal-title":"J. Eukaryot. Microbiol"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13071-021-04769-4","article-title":"\"Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned.\"","volume":"14","author":"Dubey","year":"2021","journal-title":"Parasit. Vectors"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"\"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106313_bib54","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.molimm.2010.05.008","article-title":"\"Role and mechanism of action of complement in regulating t cell immunity","volume":"47","author":"Dunkelberger","year":"2010","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"\"Association of schizophrenia and autoimmune diseases: linkage of danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106313_bib56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/icb.2011.93","article-title":"\"Insights into inflammatory bowel disease using toxoplasma gondii as an infectious trigger","volume":"90","author":"Egan","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib57","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnen\/nlae058","article-title":"\"Polymicrobial brain abscesses: a complex condition with diagnostic and therapeutic challenges","volume":"83","author":"Eichorn","year":"2024","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01003-21","article-title":"\"Valproic acid inhibits chronic toxoplasma infection and associated brain inflammation in mice","volume":"65","author":"Enshaeieh","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"\"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molimm.2019.07.018","article-title":"\"The hijackers guide to escaping complement: lessons learned from pathogens","volume":"114","author":"Ermert","year":"2019","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-021-02370-1","article-title":"\"Immune response and pathogen invasion at the choroid plexus in the onset of cerebral toxoplasmosis.\"","volume":"19","author":"Figueiredo","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106313_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008097","article-title":"\"Human immunity to toxoplasma gondii","volume":"15","author":"Fisch","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.neubiorev.2025.106313_bib63","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3389\/fpsyt.2019.01012","article-title":"\"Negative effects of latent toxoplasmosis on mental health.\"","volume":"10","author":"Flegr","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib64","doi-asserted-by":"crossref","unstructured":"Flegr, J., A. Latifi and \u0160. Ka\u0148kov\u00e1 (2024). \"<em>Toxoplasma<\/em> Infection and Its Sequential Impact on Physical Health, Stress, and Anxiety: A Large Cross-Sectional Study Testing the Stress-Coping Hypothesis.\" medRxiv: 2024.2010.2021.24315879.","DOI":"10.1101\/2024.10.21.24315879"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"\"Gut-brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106313_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697313","article-title":"\"Expanding horizons in complement analysis and quality control.\"","volume":"12","author":"Frazer-Abel","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13279","article-title":"\"Co- and polymicrobial infections in the gut mucosa: the host-microbiota-pathogen perspective","volume":"23","author":"Frisan","year":"2021","journal-title":"Cell Microbiol"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0014-4894(89)90133-1","article-title":"\"Complement evasion by protozoa","volume":"68","author":"Fuhrman","year":"1989","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib69","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4049\/jimmunol.142.3.940","article-title":"\"Toxoplasma gondii: mechanism of resistance to complement-mediated killing","volume":"142","author":"Fuhrman","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib70","doi-asserted-by":"crossref","DOI":"10.14411\/fp.2024.016","article-title":"\"The linking of toxoplasmosis and schizophrenia","volume":"71","author":"Fuller Torrey","year":"2024","journal-title":"Folia Parasitol. (Praha"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib71","first-page":"621","article-title":"\"Pure suspension of toxoplasma gondii for use in complement-fixation test","volume":"5","author":"Fulton","year":"1962","journal-title":"Immunology"},{"key":"10.1016\/j.neubiorev.2025.106313_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00052","article-title":"\"Diversity of toxoplasma gondii strains at the global level and its determinants","volume":"15","author":"Galal","year":"2019","journal-title":"Food Waterborne Parasitol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib73","article-title":"\"The robogut: a bioreactor model of the human colon for evaluation of gut microbial community ecology and function.\"","volume":"3","author":"Gianetto-Hill","year":"2023","journal-title":"Curr. Protoc."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"\"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib75","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1038\/s41467-022-33797-6","article-title":"\"Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia.\"","volume":"13","author":"Gracias","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib76","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41467-025-56128-x","article-title":"\"The toxoplasma rhoptry protein ROP55 is a major virulence factor that prevents lytic host cell death.\"","volume":"16","author":"Grilo Ruivo","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2011.01.030","article-title":"\"The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia","volume":"70","author":"Havik","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygeno.2015.11.003","article-title":"\"The sequence of sequencers: the history of sequencing DNA","volume":"107","author":"Heather","year":"2016","journal-title":"Genomics"},{"key":"10.1016\/j.neubiorev.2025.106313_bib79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-5-48","article-title":"\"Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection","volume":"5","author":"Hermes","year":"2008","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41380-021-01197-9","article-title":"\"Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis","volume":"27","author":"Heurich","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"7610","key":"10.1016\/j.neubiorev.2025.106313_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"\"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800271","article-title":"\"A Double-Edged sword: complement component 3 in toxoplasma gondii infection","volume":"19","author":"Huang","year":"2019","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ibd\/izac212","article-title":"\"Molecular and functional characterization of human intestinal organoids and monolayers for modeling epithelial barrier","volume":"29","author":"Jelinsky","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib84","doi-asserted-by":"crossref","first-page":"2096993","DOI":"10.1080\/19490976.2022.2096993","article-title":"\"The mini colon model: a benchtop multi-bioreactor system to investigate the gut microbiome","volume":"14","author":"Jin","year":"2022","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib85","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"\"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of toxoplasma gondii.\"","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res"},{"issue":"7813","key":"10.1016\/j.neubiorev.2025.106313_bib86","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41586-020-2277-x","article-title":"\"Complement genes contribute sex-biased vulnerability in diverse disorders","volume":"582","author":"Kamitaki","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2016.03.005","article-title":"\"Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to toxoplasma gondii","volume":"91","author":"Kannan","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106313_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.162","article-title":"\"Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia","volume":"7","author":"Kannan","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00855-24","article-title":"\"Motility-dependent processes in toxoplasma gondii tachyzoites and bradyzoites: same same but different","volume":"10","author":"Kent","year":"2025","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2013.09.006","article-title":"\"The next-generation sequencing revolution and its impact on genomics","volume":"155","author":"Koboldt","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2025.106313_bib91","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nmicrobiol.2016.1","article-title":"\"Endothelial cells are a replicative niche for entry of toxoplasma gondii to the central nervous system","volume":"1","author":"Konradt","year":"2016","journal-title":"Nat. Microbiol"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib92","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0004-28032010000300006","article-title":"\"Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate crohn's disease from celiac disease","volume":"47","author":"Kotze","year":"2010","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib93","first-page":"134","article-title":"Studies on toxoplasmosis in mental diseases]","volume":"5","author":"Kozar","year":"1953","journal-title":"Biul. Panstw. Inst. Med Morsk. Trop. J. W Gdan."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ejcn.2014.130","article-title":"\"Associations between diet quality and mental health in socially disadvantaged New Zealand adolescents","volume":"69","author":"Kulkarni","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib95","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1462-5822.2009.01417.x","article-title":"\"Modelling parasite dissemination: host cell subversion and immune evasion by toxoplasma gondii","volume":"12","author":"Lambert","year":"2010","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib96","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00137.2017","article-title":"\"The diverse cellular responses of the choroid plexus during infection of the central nervous system","volume":"314","author":"Lauer","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib97","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5483\/BMBRep.2015.48.4.275","article-title":"\"Technical and clinical aspects of cortisol as a biochemical marker of chronic stress","volume":"48","author":"Lee","year":"2015","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00406-004-0481-6","article-title":"\"Antibodies to infectious agents in individuals with recent onset schizophrenia","volume":"254","author":"Leweke","year":"2004","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00398-18","article-title":"\"Chronic toxoplasma gondii infection induces Anti-N-Methyl-d-Aspartate receptor autoantibodies and associated behavioral changes and neuropathology","volume":"86","author":"Li","year":"2018","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106313_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00139-19","article-title":"\"Persistent toxoplasma infection of the brain induced neurodegeneration associated with activation of complement and microglia","volume":"87","author":"Li","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neubiorev.2025.106313_bib101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12888-016-0923-5","article-title":"\"No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a han Chinese population","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0924-977X(99)00062-0","article-title":"\"Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics","volume":"10","author":"Maes","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10753-015-0262-6","article-title":"\"Toxoplasma gondii infection promotes neuroinflammation through cytokine networks and induced hyperalgesia in BALB\/c mice","volume":"39","author":"Mahmoudvand","year":"2016","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00042737-200601000-00013","article-title":"\"Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet","volume":"18","author":"Mallant-Hent","year":"2006","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218937","article-title":"\"The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice","volume":"14","author":"May","year":"2019","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.neubiorev.2025.106313_bib106","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","article-title":"\"Gut microbes and the brain: paradigm shift in neuroscience","volume":"34","author":"Mayer","year":"2014","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106313_bib107","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13238-012-2924-6","article-title":"\"Complement genetics, deficiencies, and disease associations","volume":"3","author":"Mayilyan","year":"2012","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib108","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/15622970701227803","article-title":"\"Complement C4B protein in schizophrenia","volume":"9","author":"Mayilyan","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib109","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1358\/dnp.2008.21.4.1213349","article-title":"\"The complement system in schizophrenia","volume":"21","author":"Mayilyan","year":"2008","journal-title":"Drug N. Perspect."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib110","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","article-title":"\"A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia","volume":"27","author":"McGuinness","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2500\/aap.2024.45.240050","article-title":"\"Immunodeficiency: complement disorders","volume":"45","author":"McMurray","year":"2024","journal-title":"Allergy Asthma Proc."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2025.106313_bib112","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejphar.2010.11.010","article-title":"\"Chronic risperidone normalizes elevated pro-inflammatory cytokine and C-reactive protein production in omega-3 fatty acid deficient rats","volume":"652","author":"McNamara","year":"2011","journal-title":"Eur. J. Pharm."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib113","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pt.2011.08.001","article-title":"\"Toxoplasma gondii effectors are master regulators of the inflammatory response","volume":"27","author":"Melo","year":"2011","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib114","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.encep.2023.08.002","article-title":"\"CSMD1 rs10503253 increases schizophrenia risk in a Tunisian population-group","volume":"50","author":"Mihoub","year":"2024","journal-title":"Encephale"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pt.2022.10.003","article-title":"\"Is the incidence of congenital toxoplasmosis declining?\"","volume":"39","author":"Milne","year":"2023","journal-title":"Trends Parasitol."},{"issue":"9425","key":"10.1016\/j.neubiorev.2025.106313_bib116","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"\"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020619","article-title":"\"Gut-on-a-Chip models: current and future perspectives for Host-Microbial interactions research","volume":"11","author":"Morelli","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2025.106313_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105840","article-title":"\"Association of complement component 4 with neuroimmune abnormalities in the subventricular zone in schizophrenia and autism spectrum disorders","volume":"173","author":"Mou","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib119","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"\"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"Muller","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106313_bib120","unstructured":"Murphy, K., P. Travers, M. Walport and C. Janeway (2012). Janeway's immunobiology. New York, Garland Science."},{"issue":"6917","key":"10.1016\/j.neubiorev.2025.106313_bib121","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"\"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib122","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2020.10.003","article-title":"\"Gut microbiome in schizophrenia: altered functional pathways related to immune modulation and atherosclerotic risk.\"","volume":"91","author":"Nguyen","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2025.106313_bib123","first-page":"855","article-title":"\"La reaction de fixation du complement dans le serum et dans les extraits d\u2019organes d\u2019animaux attteints de toxoplasmose experimentale","volume":"30","author":"Nicolau","year":"1937","journal-title":"Bull. Soc. Path. Exot."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1176\/appi.ajp.2007.06081254","article-title":"\"Selected infectious agents and risk of schizophrenia among U.S. Military personnel","volume":"165","author":"Niebuhr","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib125","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/mp.2017.151","article-title":"\"The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis","volume":"22","author":"Nimgaonkar","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106313_bib126","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1046\/j.1440-1746.2000.02357.x","article-title":"\"Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with crohn's disease","volume":"15","author":"Oshitani","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib127","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archgenpsychiatry.2012.668","article-title":"\"Toxoplasma gondii infection and self-directed violence in mothers","volume":"69","author":"Pedersen","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib128","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41380-024-02701-7","article-title":"\"The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking","volume":"30","author":"Phadke","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib129","first-page":"2308619","article-title":"\"Toxoplasma gondii-Induced Long-Term changes in the upper intestinal microflora during the chronic stage of infection","volume":"2018","author":"Prandovszky","year":"2018","journal-title":"Sci. (Cairo)"},{"key":"10.1016\/j.neubiorev.2025.106313_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1415079","article-title":"\"Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?\"","volume":"14","author":"Prandovszky","year":"2024","journal-title":"Front Cell Infect. Microbiol"},{"issue":"7256","key":"10.1016\/j.neubiorev.2025.106313_bib131","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"\"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104894","article-title":"\"Schizophrenia: the new etiological synthesis.\"","volume":"142","author":"Rantala","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111564","article-title":"\"The defensive interactions of prominent infectious protozoan parasites: the host's complement system","volume":"12","author":"Rashidi","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib134","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000504495","article-title":"\"Gut microbiota: a perspective for psychiatrists","volume":"79","author":"Rea","year":"2020","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106313_bib135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0278-5846(96)00099-1","article-title":"\"Could schizophrenia be reasonably explained by dohan's hypothesis on genetic interaction with a dietary peptide overload?\"","volume":"20","author":"Reichelt","year":"1996","journal-title":"Prog. NeuroPsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib136","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2022.05.118","article-title":"\"How to get away with murder: the multiple strategies employed by pathogenic protozoa to avoid complement killing.\"","volume":"149","author":"Rios-Barros","year":"2022","journal-title":"Mol. Immunol."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2025.106313_bib137","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"\"Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?\"","volume":"140","author":"R\u00f8ge","year":"2012","journal-title":"Schizophr. Res"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib138","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pt.2022.02.003","article-title":"\"Early passage of toxoplasma gondii across the blood-brain barrier","volume":"38","author":"Ross","year":"2022","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib139","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000153549","article-title":"\"Complement factor C4 in schizophrenia","volume":"35","author":"Rudduck","year":"1985","journal-title":"Hum. Hered."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.4.4.443","article-title":"\"Complement fixation test in toxoplasmosis and persistence of the antibody in human beings","volume":"4","author":"Sabin","year":"1949","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib141","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ni1102-1041","article-title":"\"Evasion of innate immunity by parasitic protozoa","volume":"3","author":"Sacks","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108457","article-title":"\"A major toxoplasma serine protease inhibitor protects the parasite against gut-derived serine proteases and NETosis damage","author":"Saffarian","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib143","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0022-2836(75)90213-2","article-title":"\"A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase","volume":"94","author":"Sanger","year":"1975","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib144","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"\"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"issue":"7510","key":"10.1016\/j.neubiorev.2025.106313_bib145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"\"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112886","article-title":"\"The gut microbiome and antipsychotic treatment response","volume":"396","author":"Seeman","year":"2021","journal-title":"Behav. Brain Res"},{"issue":"7589","key":"10.1016\/j.neubiorev.2025.106313_bib147","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"\"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib148","doi-asserted-by":"crossref","first-page":"1134471","DOI":"10.3389\/fcimb.2023.1134471","article-title":"\"Exploring toxoplasma gondii\u00b4s biology within the intestinal epithelium: intestinal-derived models to unravel sexual differentiation.\"","volume":"13","author":"Sena","year":"2023","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.neubiorev.2025.106313_bib149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/7854_2022_364","article-title":"\"Fungal forces in mental health: microbial meddlers or function fixers?\"","volume":"61","author":"Severance","year":"2023","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106313_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2024.100085","article-title":"\"Gut-brain axis system updates: optimizing microbiome biomarkers for psychiatry and neurology","volume":"10","author":"Severance","year":"2024","journal-title":"Biomark. Neuropsychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib151","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/7854_2018_84","article-title":"\"From infection to the microbiome: an evolving role of microbes in schizophrenia","volume":"44","author":"Severance","year":"2020","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106313_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2019.100009","article-title":"\"Tracking a dysregulated gut-brain axis with biomarkers of the microbiome","volume":"2","author":"Severance","year":"2020","journal-title":"Biomark. Neuropsychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2021.05.002","article-title":"\"Guest editorial: binning bugs and beyond: the state of the schizophrenia microbiome","volume":"234","author":"Severance","year":"2021","journal-title":"Schizophr. Res"},{"issue":"1-3","key":"10.1016\/j.neubiorev.2025.106313_bib154","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2010.12.001","article-title":"\"Dietary antigens, epitope recognition, and immune complex formation in recent onset psychosis and long-term schizophrenia","volume":"126","author":"Severance","year":"2011","journal-title":"Schizophr. Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2012.02.025","article-title":"\"Gastrointestinal inflammation and associated immune activation in schizophrenia","volume":"138","author":"Severance","year":"2012","journal-title":"Schizophr. Res"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050991","article-title":"\"Anti-gluten immune response following toxoplasma gondii infection in mice","volume":"7","author":"Severance","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib157","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nbd.2012.07.005","article-title":"\"Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia","volume":"48","author":"Severance","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2025.106313_bib158","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2013.05.018","article-title":"\"Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia","volume":"148","author":"Severance","year":"2013","journal-title":"Schizophr. Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib159","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2014.07.053","article-title":"\"Maternal complement C1q and increased odds for psychosis in adult offspring","volume":"159","author":"Severance","year":"2014","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.neubiorev.2025.106313_bib160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbi.2014.09.009","article-title":"\"IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia","volume":"44","author":"Severance","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib161","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11920-015-0574-0","article-title":"\"Gastroenterology issues in schizophrenia: why the gut matters","volume":"17","author":"Severance","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2025.106313_bib162","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.irn.2016.08.008","article-title":"\"Toxoplasma gondii-A gastrointestinal pathogen associated with human brain diseases.\"","volume":"131","author":"Severance","year":"2016","journal-title":"Int Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib163","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2014.06.027","article-title":"\"Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling","volume":"176","author":"Severance","year":"2016","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.neubiorev.2025.106313_bib164","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/npjschz.2016.18","article-title":"\"Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder","volume":"2","author":"Severance","year":"2016","journal-title":"NPJ Schizophr."},{"issue":"40","key":"10.1016\/j.neubiorev.2025.106313_bib165","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.2174\/1381612822666160914183804","article-title":"\"The gut microbiota and the emergence of autoimmunity: relevance to major psychiatric disorders","volume":"22","author":"Severance","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2025.106313_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2018.05.005","article-title":"\"Autoimmune phenotypes in schizophrenia reveal novel treatment targets","author":"Severance","year":"2018","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.neubiorev.2025.106313_bib167","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fpsyt.2020.00549","article-title":"\"Complex gastrointestinal and endocrine sources of inflammation in schizophrenia","volume":"11","author":"Severance","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib168","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2021.02.001","article-title":"\"Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia","volume":"234","author":"Severance","year":"2021","journal-title":"Schizophr. Res"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib169","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000534185","article-title":"\"Prospects and pitfalls of plasma complement C4 in schizophrenia: building a better biomarker","volume":"45","author":"Severance","year":"2023","journal-title":"Dev. Neurosci."},{"issue":"7256","key":"10.1016\/j.neubiorev.2025.106313_bib170","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","article-title":"\"Common variants on chromosome 6p22.1 are associated with schizophrenia","volume":"460","author":"Shi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib171","article-title":"\"Toxoplasma infection induces sustained Up-Regulation of complement factor b and C5a receptor in the mouse brain via microglial activation: implication for the alternative complement pathway activation and anaphylatoxin signaling in cerebral toxoplasmosis","volume":"11","author":"Shinjyo","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib172","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.3389\/fimmu.2019.03105","article-title":"\"Toxoplasma gondii recruits factor h and C4b-Binding protein to mediate resistance to serum killing and promote parasite persistence in vivo","volume":"10","author":"Sikorski","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.634610","article-title":"\"A protective and pathogenic role for complement during acute toxoplasma gondii infection","volume":"11","author":"Sikorski","year":"2021","journal-title":"Front Cell Infect. Microbiol"},{"issue":"19","key":"10.1016\/j.neubiorev.2025.106313_bib174","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2174\/1568026618666181115100610","article-title":"\"Recognizing the leaky gut as a Trans-diagnostic target for neuroimmune disorders using clinical chemistry and molecular immunology assays","volume":"18","author":"Simeonova","year":"2018","journal-title":"Curr. Top. Med Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(99)00116-4","article-title":"\"Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist","volume":"42","author":"Song","year":"2000","journal-title":"Schizophr. Res"},{"issue":"7256","key":"10.1016\/j.neubiorev.2025.106313_bib176","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"\"Common variants conferring risk of schizophrenia.\"","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106313_bib177","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"\"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106313_bib178","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"\"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106313_bib179","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11920-019-1091-3","article-title":"\"Non-Genetic factors in schizophrenia","volume":"21","author":"Stilo","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2025.106313_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2019.102030","article-title":"\"The immune system utilizes two distinct effector mechanisms of t cells depending on two different life cycle stages of a single pathogen, toxoplasma gondii, to control its cerebral infection","volume":"76","author":"Suzuki","year":"2020","journal-title":"Parasitol. Int"},{"key":"10.1016\/j.neubiorev.2025.106313_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-025-01073-y","article-title":"\"Knowing the enemy: strategic targeting of complement to treat alzheimer disease","author":"Tenner","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib182","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","article-title":"\"New tricks for an ancient system: physiological and pathological roles of complement in the CNS","volume":"102","author":"Tenner","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116202","article-title":"\"Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency","volume":"342","author":"Teymouri","year":"2024","journal-title":"Psychiatry Res"},{"issue":"7610","key":"10.1016\/j.neubiorev.2025.106313_bib184","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","article-title":"\"The microbiome and innate immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib185","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3201\/eid0911.030143","article-title":"\"Toxoplasma gondii and schizophrenia","volume":"9","author":"Torrey","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.neubiorev.2025.106313_bib186","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.psychres.2019.06.006","article-title":"\"Schizophrenia as a pseudogenetic disease: a call for more gene-environmental studies","volume":"278","author":"Torrey","year":"2019","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib187","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"\"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106313_bib188","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-024-01788-5","article-title":"\"Hereditary C1q deficiency is associated with type 1 Interferon-Pathway activation and a high risk of central nervous system inflammation.\"","volume":"44","author":"Triaille","year":"2024","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib189","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbu069","article-title":"\u201cIdentifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.\u201d","volume":"40","author":"Van Os","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106313_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.12.014","article-title":"\"Gut microbial changes of patients with psychotic and affective disorders: a systematic review","volume":"234","author":"Vindegaard","year":"2021","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.neubiorev.2025.106313_bib191","first-page":"6634807","article-title":"\"Neurological and neurobehavioral disorders associated with toxoplasma gondii infection in humans","author":"Virus","year":"2021","journal-title":"J. Parasitol. Res 2021"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib192","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"\"10 years of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am. J. Hum. Genet"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106313_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/genes12121850","article-title":"\"Gene-Environment interactions in schizophrenia: a literature review","volume":"12","author":"Wahbeh","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.neubiorev.2025.106313_bib194","article-title":"\"Complement C4, infections, and autoimmune diseases","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106313_bib195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"\"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106313_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103216","article-title":"\"Balancing efficacy and safety of complement inhibitors.\"","volume":"145","author":"Watanabe-Kusunoki","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.neubiorev.2025.106313_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2017.12.016","article-title":"\"Monocyte activation detected prior to a diagnosis of schizophrenia in the US military new onset psychosis project (MNOPP)","author":"Weber","year":"2018","journal-title":"Schizophr. Res"},{"issue":"1589","key":"10.1016\/j.neubiorev.2025.106313_bib198","first-page":"1023","article-title":"\"Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on toxoplasma gondii's ability to alter host behaviour","volume":"273","author":"Webster","year":"2006","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106313_bib199","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2022_362","article-title":"\"Infections, inflammation, and psychiatric illness: review of postmortem evidence","author":"Webster","year":"2022","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"10424","key":"10.1016\/j.neubiorev.2025.106313_bib200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"\"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2025.106313_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.840266","article-title":"\"Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder","volume":"16","author":"Westacott","year":"2022","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106313_bib202","first-page":"303","article-title":"\"Is insanity due to a microbe","volume":"75","author":"Wise","year":"1896","journal-title":"Sci. Am."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib203","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41380-019-0479-0","article-title":"\"The complement system in schizophrenia: where are we now and what's next?\"","volume":"25","author":"Woo","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106313_bib204","doi-asserted-by":"crossref","unstructured":"Wu, M., W. Zheng, X. Song, B. Bao, Y. Wang, D. Ramanan, D. Yang, R. Liu, J.C. Macbeth, E.A. Do, W.A. Andrade, T. Yang, H.S. Cho, F.S. Gazzaniga, M. Ilves, D. Coronado, C. Thompson, S. Hang, I.M. Chiu, J.R. Moffitt, A. Hsiao, J.J. Mekalanos, C. Benoist and D.L. Kasper (2023). \"Microbiome induced complement synthesized in the gut protects against enteric infections.\" bioRxiv.","DOI":"10.1101\/2023.02.02.523770"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib205","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2023.12.036","article-title":"\"Gut complement induced by the microbiota combats pathogens and spares commensals.\"","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2025.106313_bib206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/7854_2022_370","article-title":"\"Behavioral changes induced by latent toxoplasmosis could arise from CNS inflammation and neuropathogenesis","volume":"61","author":"Xiao","year":"2023","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib207","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/apha.12458","article-title":"\"Strain hypothesis of toxoplasma gondii infection on the outcome of human diseases","volume":"213","author":"Xiao","year":"2015","journal-title":"Acta Physiol. (Oxf. )"},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106313_bib208","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.micinf.2009.07.007","article-title":"\"Serological pattern consistent with infection with type I toxoplasma gondii in mothers and risk of psychosis among adult offspring","volume":"11","author":"Xiao","year":"2009","journal-title":"Microbes Infect."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106313_bib209","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004674","article-title":"\"Behavioral abnormalities in a mouse model of chronic toxoplasmosis are associated with MAG1 antibody levels and cyst burden","volume":"10","author":"Xiao","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.neubiorev.2025.106313_bib210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbi.2016.04.009","article-title":"\"Cerebral complement C1q activation in chronic toxoplasma infection","volume":"58","author":"Xiao","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib211","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/schbul\/sby082","article-title":"\"Toxoplasma gondii: biological parameters of the connection to schizophrenia","volume":"44","author":"Xiao","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106313_bib212","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2018.03.013","article-title":"\"PD-1 immune checkpoint blockade promotes brain leukocyte infiltration and diminishes cyst burden in a mouse model of toxoplasma infection","volume":"319","author":"Xiao","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104660","article-title":"\"Strain-specific pre-existing immunity: a key to understanding the role of chronic toxoplasma infection in cognition and alzheimer's diseases?\"","volume":"137","author":"Xiao","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib214","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41598-023-28322-8","article-title":"\"Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic toxoplasma infection","volume":"13","author":"Xiao","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006040","article-title":"\"Evidence of increased exposure to toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia","volume":"11","author":"Yolken","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106313_bib216","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/319221","article-title":"\"Antibodies to toxoplasma gondii in individuals with first-episode schizophrenia","volume":"32","author":"Yolken","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106313_bib217","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","article-title":"\"Toxoplasma and schizophrenia","volume":"31","author":"Yolken","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib218","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2021.04.006","article-title":"\"Studying the virome in psychiatric disease","volume":"234","author":"Yolken","year":"2021","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.neubiorev.2025.106313_bib219","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neurobiolaging.2020.03.024","article-title":"\"The age-related microglial transformation in alzheimer's disease pathogenesis","volume":"92","author":"Yuan","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106313_bib220","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13724","article-title":"\"Advances in gut-brain organ chips","volume":"57","author":"Zhang","year":"2024","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106313_bib221","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau8317","article-title":"The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice","volume":"5","author":"Zheng","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neubiorev.2025.106313_bib222","doi-asserted-by":"crossref","unstructured":"Zhu, F., R. Guo, W. Wang, Y. Ju, Q. Wang, Q. Ma, Q. Sun, Y. Fan, Y. Xie, Z. Yang, Z. Jie, B. Zhao, L. Xiao, L. Yang, T. Zhang, B. Liu, L. Guo, X. He, Y. Chen, C. Chen, C. Gao, X. Xu, H. Yang, J. Wang, Y. Dang, L. Madsen, S. Brix, K. Kristiansen, H. Jia and X. Ma (2019). \"Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice.\" Mol Psychiatry.","DOI":"10.1038\/s41380-019-0475-4"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106313_bib223","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/s41467-020-15457-9","article-title":"Metagenome-wide association of gut microbiome features for schizophrenia","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2025.106313_bib224","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molimm.2025.05.003","article-title":"Comparative transcriptomic analyses of macrophages infected with toxoplasma gondii strains of different virulence provide molecular insights into the response of macrophage in phagocytosis and polarization to infection","volume":"183","author":"Zhu","year":"2025","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106313_bib225","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.858989","article-title":"Distinct phenotypes of inflammation associated macrophages and microglia in the prefrontal cortex schizophrenia compared to controls","volume":"16","author":"Zhu","year":"2022","journal-title":"Front Neurosci."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425003148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425003148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T22:03:10Z","timestamp":1762034590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":225,"alternative-id":["S0149763425003148"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106313","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation manipulation and a complement-centered reboot of the Toxoplasma gondii model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106313"}}